keyword
Keywords Pulmonary Embolism AND Thrombo...

Pulmonary Embolism AND Thromboelastography

https://read.qxmd.com/read/37839099/thromboembolic-complications-following-perioperative-tranexamic-acid-administration
#1
JOURNAL ARTICLE
Ella C Eisinger, Liam Forsythe, Sarah Joergensen, Shyam Murali, Jeremy W Cannon, Patrick M Reilly, Patrick K Kim, Elinore J Kaufman
INTRODUCTION: The antifibrinolytic tranexamic acid (TXA) may reduce death in trauma; however, outcomes associated with TXA use in patients without proven hyperfibrinolysis remain unclear. We analyzed the associations of empirically administered TXA, hypothesizing that TXA use would correlate to lower transfusion totals but increased thromboembolic complications. METHODS: This retrospective cohort study compared trauma patients started on massive transfusion protocol at a Level I trauma center from 2016 to 2021 who either did or did not receive TXA...
January 2024: Journal of Surgical Research
https://read.qxmd.com/read/36292507/changes-of-coagulation-and-fibrinolytic-status-detected-by-thromboelastography-teg6s-%C3%A2-in-pregnancy-labor-early-postpartum-postpartum-hemorrhage-and-heparin-treatment-for-perinatal-venous-thrombosis
#2
JOURNAL ARTICLE
Chiharu Suemitsu, Megumi Fudaba, Kohei Kitada, Yasushi Kurihara, Mie Tahara, Akihiro Hamuro, Takuya Misugi, Akemi Nakano, Masayasu Koyama, Daisuke Tachibana
The aims of this study are to evaluate coagulation and fibrinolytic features using TEG6s® in normal pregnant courses, in the early postpartum period and in cases with postpartum hemorrhage (PPH) caused by uterine atony. We also analyze cases with deep venous thrombosis (DVT) and/or pulmonary embolism (PE) under treatment with unfractionated heparin. The non-pregnant women ( n = 13) and healthy pregnant women (at 9-13 weeks of gestation ( n = 13), at 27-30 weeks of gestation ( n = 14), at 35-38 weeks of gestation ( n = 14)) were cross-sectionally studied, while the normal pregnant women at delivery ( n = 14) were sequentially investigated...
October 17, 2022: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/36286308/role-of-fibrinolysis-in-the-management-of-patients-with-covid-19-and-thromboembolic-complications-a-review
#3
REVIEW
Patrycja Zając, Karol Kaziród-Wolski, Izabela Oleś, Janusz Sielski, Zbigniew Siudak
An impaired fibrinolytic process has been demonstrated in patients infected with SARS-CoV-2, including those in severe or critical condition. Disruption of fibrinolysis leads to fibrin deposition, which exacerbates inflammation and fibrosis and damages the pulmonary surfactant. Numerous authors point out the different course of coagulopathy in patients with COVID-19. It is reported that they may have a state of secondary hyperfibrinolysis, which may explain, at least in part, the increased incidence of venous thromboembolism, even among those patients already receiving appropriate anticoagulant treatment...
October 17, 2022: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/35901446/what-proportion-of-patients-with-musculoskeletal-tumors-demonstrate-thromboelastographic-markers-of-hypercoagulability-a-pilot-study
#4
JOURNAL ARTICLE
Samir Sabharwal, Hulai B Jalloh, Adam S Levin, Carol D Morris
BACKGROUND: Thromboelastography (TEG) is a point-of-care venipuncture test that measures the elasticity and strength of a clot formed from a patient's blood, providing a more comprehensive analysis of a patient's coagulation status than conventional measures of coagulation. TEG includes four primary markers: R-time, which measures the time to clot initiation and is a proxy for platelet function; K-value, which measures the time for said clot to reach an amplitude of 20 mm and is a proxy for fibrin cross-linking; maximum amplitude (MA), which measures the clot's maximum amplitude and is a proxy for platelet aggregation; and LY30, which measures the percentage of clot lysis 30 minutes after reaching the MA and is a proxy for fibrinolysis...
July 12, 2022: Clinical Orthopaedics and related Research
https://read.qxmd.com/read/35829956/prevention-of-deep-vein-thrombosis-by-panax-notoginseng-saponins-combined-with-low-molecular-weight-heparin-in-surgical-patients
#5
JOURNAL ARTICLE
Chun-Mei Wang, Xiang-Feng Guo, Li-Min Liu, Ying Huang, Liang Meng, Li-Po Song, Ying-Feng Wu, Ya-Chan Ning, Kathleen H Reilly, Hai-Bo Wang
OBJECTIVE: To evaluate the efficacy of deep vein thrombosis (DVT) prevention among real-world surgical inpatients who received panax notoginseng saponins (PNS) combined with low-molecular-weight heparin (LMWH). METHODS: A prospective cohort study was conducted among surgical patients between January 2016 and November 2018 in Xuanwu Hospital, Capital Medical University, Beijing, China. Participants received LMWH alone or PNS combined with LMWH for preventing DVT...
September 2022: Chinese Journal of Integrative Medicine
https://read.qxmd.com/read/35468241/what-is-the-optimal-prophylaxis-against-postoperative-deep-vein-thrombosis-in-the-living-donor-to-avoid-complications-and-enhance-recovery-a-systematic-review-of-the-literature-and-expert-panel-recommendations
#6
JOURNAL ARTICLE
Luis I Ruffolo, Mark Levstik, Jen Boehly, Michael Spiro, Dimitri A Raptis, Linda Liu, Roberto Hernandez-Alejandro
BACKGROUND: Deep venous thrombosis (DVT) prophylaxis is often employed to prevent the potentially serious complication of pulmonary embolism (PE). However, little data exist regarding the optimal DVT prophylaxis strategy for living donors undergoing hepatectomy for living donor liver transplantation. Here we present our consensus statement on DVT prophylaxis for living donors undergoing hepatectomy. OBJECTIVES: To identify the optimal DVT prophylaxis strategy which reduces risk of complications in living liver donors, and enhances recovery...
April 25, 2022: Clinical Transplantation
https://read.qxmd.com/read/35072082/serial-thromboelastography-and-the-development-of-venous-thromboembolism-in-critically-ill-patients-with-covid-19
#7
JOURNAL ARTICLE
Tanya K Marvi, William B Stubblefield, Benjamin F Tillman, Mark W Tenforde, Manish M Patel, Christopher J Lindsell, Wesley H Self, Carlos G Grijalva, Todd W Rice
To test the hypothesis that relatively lower clot strength on thromboelastography maximum amplitude (MA) is associated with development of venous thromboembolism (VTE) in critically ill patients with COVID-19. DESIGN: Prospective, observational cohort study. SETTING: Tertiary care, academic medical center in Nashville, TN. PATIENTS: Patients with acute respiratory failure from COVID-19 pneumonia admitted to the adult medical ICU without known VTE at enrollment...
January 2022: Critical care explorations
https://read.qxmd.com/read/34550034/application-of-thromboelastography-in-comparing-coagulation-difference-of-rivaroxaban-and-enoxaparin-for-thromboprophylaxis-after-total-hip-arthroplasty
#8
RANDOMIZED CONTROLLED TRIAL
Chao-Wen Bai, Ru-Xin Ruan, Sheng Pan, Chao-Ran Huang, Xing-Chen Zhang, Yong Pang, Xin Zheng, Kai-Jin Guo
Purpose: The purpose of this study was to compare the coagulation difference in patients with either rivaroxaban or enoxaparin as thromboprophylaxis after total hip arthroplasty (THA) regarding thromboelastography (TEG) and routine coagulation tests. Patients and methods: Two hundred and twenty-eight patients undergoing primary THA were recruited in this study. They were divided into two groups according to a computer-generated random sequence. Patients in the rivaroxaban group received 10 mg of rivaroxaban orally once daily...
September 2021: Journal of Orthopaedic Surgery
https://read.qxmd.com/read/34103743/hypercoagulability-on-thromboelastography-after-living-donor-hepatectomy-the-true-side-of-the-coin
#9
JOURNAL ARTICLE
Shankey Garg, Gaurav Sindwani, Neha Garg, Mahesh K Arora, Viniyendra Pamecha, Deepak Tempe
BACKGROUND AND AIMS: Coagulation dynamics after donor hepatectomy are complex. Having complete knowledge of the actual changes in the coagulation status during donor hepatectomy is important to prevent complications such as pulmonary embolism, deep vein thrombosis, and bleeding. Hence, the present study aimed to study the coagulation dynamics following open donor hepatectomy both by thromboelastography (TEG) and conventional coagulation tests (CCT). METHODS: A total of 50 prospective liver donors were included...
April 2021: Indian Journal of Anaesthesia
https://read.qxmd.com/read/33786433/thromboelastography-parameters-and-platelet-count-on-admission-to-the-icu-and-the-development-of-venous-thromboembolism-in-patients-with-coronavirus-disease-2019
#10
JOURNAL ARTICLE
Tanya K Marvi, William B Stubblefield, Benjamin F Tillman, Mark W Tenforde, Leora R Feldstein, Manish M Patel, Wesley H Self, Carlos G Grijalva, Todd W Rice
OBJECTIVES: Determine if thromboelastography parameters and platelet count on the day of ICU admission are associated with the development of venous thromboembolism in patients with coronavirus disease 2019. DESIGN: Prospective, observational cohort study. SETTING: Tertiary-care, academic medical center in Nashville, TN. PATIENTS: Patients with coronavirus disease 2019 pneumonia and acute respiratory failure admitted to the adult ICU without venous thromboembolism at the time of ICU admission...
March 2021: Critical care explorations
https://read.qxmd.com/read/33364605/thromboembolism-hypercoagulopathy-and-antiphospholipid-antibodies-in-critically-ill-coronavirus-disease-2019-patients-a-before-and-after-study-of-enhanced-anticoagulation
#11
JOURNAL ARTICLE
Jan van der Linden, Lou Almskog, Andreas Liliequist, Jonathan Grip, Thomas Fux, Susanne Rysz, Anna Ågren, Anders Oldner, Marcus Ståhlberg
To determine the prevalence of thrombotic events, functional coagulation tests, inflammatory biomarkers, and antiphospholipid antibodies before and after enhanced anticoagulation in critically ill coronavirus disease 2019 patients. Design: Retrospective. Setting: Tertiary intensive care unit. Patients: Two cross-sectional cohorts of ICU-treated coronavirus disease 2019 patients were included before (cohort 1, n = 12) and after (cohort 2, n = 14) enhanced prophylactic anticoagulation strategy...
December 2020: Critical care explorations
https://read.qxmd.com/read/33205407/utility-of-coagulation-analyses-to-assess-thromboprophylaxis-with-dalteparin-in-intensive-care-unit-patients
#12
JOURNAL ARTICLE
Nina Gjerde Andersen, Marie-Christine Mowinckel, Kjetil Sunde, Per Morten Sandset, Sigrid Beitland
BACKGROUND: The aim of this study was to evaluate the utility of coagulation analyses to assess thromboprophylaxis with dalteparin in intensive care unit (ICU) patients. METHODS: Prospective observational study of ICU patients receiving dalteparin prophylaxis at Oslo University Hospital in Norway. Trough and peak antithrombin, protein C, anti-factor Xa activity (aFXa), d-dimer, thromboelastography, calibrated automated thrombogram and microparticles were analysed...
November 18, 2020: Acta Anaesthesiologica Scandinavica
https://read.qxmd.com/read/32948243/thrombotic-and-haemorrhagic-complications-in-critically-ill-patients-with-covid-19-a-multicentre-observational-study
#13
MULTICENTER STUDY
Akshay Shah, Killian Donovan, Anna McHugh, Manish Pandey, Louise Aaron, Charlotte A Bradbury, Simon J Stanworth, Raza Alikhan, Stephen Von Kier, Keith Maher, Nicola Curry, Susan Shapiro, Matthew J Rowland, Matt Thomas, Richard Mason, Matthew Holland, Tom Holmes, Michael Ware, Stefan Gurney, Stuart R McKechnie
BACKGROUND: Optimal prophylactic and therapeutic management of thromboembolic disease in patients with COVID-19 remains a major challenge for clinicians. The aim of this study was to define the incidence of thrombotic and haemorrhagic complications in critically ill patients with COVID-19. In addition, we sought to characterise coagulation profiles using thromboelastography and explore possible biological differences between patients with and without thrombotic complications. METHODS: We conducted a multicentre retrospective observational study evaluating all the COVID-19 patients received in four intensive care units (ICUs) of four tertiary hospitals in the UK between March 15, 2020, and May 05, 2020...
September 18, 2020: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/32455509/coagulation-in-liver-surgery-an-observational-haemostatic-profile-and-thromboelastography-study
#14
JOURNAL ARTICLE
June Oo, Megan Allen, Benjamin P T Loveday, Nora Lee, Brett Knowles, Bernhard Riedel, Kate Burbury, Benjamin Thomson
BACKGROUND: International normalized ratio (INR) is used as a marker of the haemostatic status following liver resection. However, the impact of liver resection on haemostasis is complex and beyond what can be measured by INR. This study aimed to prospectively assess haemostatic profile following liver resection and determine if INR measurement can safely guide post-operative thromboprophylaxis. METHODS: In this prospective cohort study, patients undergoing liver resection had coagulation parameters (International normalised ratio (INR), prothrombin time (PT), activated partial thromboplastin time, fibrinogen, d-dimer, von Willebrand factor antigen, procoagulant activity of phospholipids and clotting factors II, VII, VIIIc, IX and X) and thromboelastogram parameters assessed perioperatively...
June 2020: ANZ Journal of Surgery
https://read.qxmd.com/read/31940502/inhaled-nitric-oxide-to-control-platelet-hyper-reactivity-in-patients-with-acute-submassive-pulmonary-embolism
#15
JOURNAL ARTICLE
Jeffrey A Kline, Michael A Puskarich, Jonathan W Pike, John Zagorski, Nathan J Alves
BACKGROUND: We test if inhaled nitric oxide (NO) attenuates platelet functional and metabolic hyper-reactivity in subjects with submassive pulmonary embolism (PE). METHODS: Participants with PE were randomized to either 50 ppm NO + O2 or O2 only for 24 h with blood sampling at enrollment and after treatment; results were compared with healthy controls. Platelet metabolic activity was assessed by oxygen consumption (basal and uncoupled) and reactivity was assessed with agonist-stimulated thromboelastography (TEG) and fluorometric measurement of agonist-stimulated cytosolic [Ca++ ] without and with pharmacological soluble guanylate (sGC) modulation...
March 1, 2020: Nitric Oxide: Biology and Chemistry
https://read.qxmd.com/read/31829245/application-of-thromboelastography-to-evaluate-the-effect-of-different-routes-administration-of-tranexamic-acid-on-coagulation-function-in-total-hip-arthroplasty
#16
RANDOMIZED CONTROLLED TRIAL
Xingming Xu, Jiang Jiang, Wei Liu, Xiaofeng Li, Huading Lu
BACKGROUND: Tranexamic acid (TXA) is widely used to reduce blood loss and transfusion rates in total hip arthroplasty(THA). Thromboelastography, which can monitor coagulation changes from clotting to fibrinolysis dynamically. In this study, thromboelastography was used to assess the dynamic changes in the coagulation of patients who underwent THA with the administration of TXA. METHODS: This randomized controlled trial consisted of 207 consecutive patients who underwent primary total hip arthroplasty...
December 11, 2019: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/31815829/ability-of-thromboelastography-to-detect-hypercoagulability-a-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Wesley Brown, Matthew Lunati, Michael Maceroli, Alexandra Ernst, Christopher Staley, Richard Johnson, Mara Schenker
OBJECTIVE: To review the current literature on the use of viscoelastic hemolytic assays, such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM), during the perioperative period of patients and determine the ability of TEG and ROTEM to detect hypercoagulability and identify increased risk of the development of venous thromboembolism (VTE). DATA SOURCES: PubMed, EMBASE, and Cochrane online databases were queried through February 11, 2018, by pairing the terms "thromboelastography," "viscoelastic hemostatic assays," and "rotational thromboelastometry" with "venous thromboembolism," "deep vein thrombosis," "pulmonary embolism," and "hypercoagulability...
June 2020: Journal of Orthopaedic Trauma
https://read.qxmd.com/read/30548128/fibrinolysis-shutdown-is-associated-with-thrombotic-and-hemorrhagic-complications-and-poorer-outcomes-after-liver-transplantation
#18
JOURNAL ARTICLE
Ramona Nicolau-Raducu, Thiago Beduschi, Rodrigo Vianna, Christian Diez, Mahmoud Sleem, Bhavna P Singh, Georgia Vasileiou, Yehuda Raveh
Detrimental consequences of hypofibrinolysis, also known as fibrinolysis shutdown (FS), have recently arisen, and its significance in liver transplantation (LT) remains unknown. To fill this gap, this retrospective study included 166 adults who received transplants between 2016 and 2018 for whom baseline thromboelastography was available. On the basis of percent of clot lysis 30 minutes after maximal amplitude, patients were stratified into 3 fibrinolysis phenotypes: FS, physiologic fibrinolysis, and hyperfibrinolysis...
March 2019: Liver Transplantation
https://read.qxmd.com/read/30279053/rotational-thromboelastometry-rotem%C3%A2-guided-diagnosis-and-management-of-amniotic-fluid-embolism
#19
JOURNAL ARTICLE
J A Loughran, T L Kitchen, S Sindhakar, M Ashraf, M Awad, E J Kealaher
Amniotic fluid embolism is a rare but often catastrophic emergency. The non-specific clinical features and lack of diagnostic tests make it a diagnosis of exclusion. Point-of-care visco-elastometric testing is being increasingly used during obstetric haemorrhage. We present a case of amniotic fluid embolism, diagnosed and managed using rotational thromboelastography. During a precipitous labour, a 21-year-old multiparous woman became pale, distressed and disorientated. The fetus was delivered using forceps...
May 2019: International Journal of Obstetric Anesthesia
https://read.qxmd.com/read/30045793/-risk-of-anticoagulation-therapy-in-surgical-intensive-care-unit-patients-predicted-by-thromboelastograph
#20
JOURNAL ARTICLE
Zixia Wu, Zhiyong Liu, Wei Zhang, Wenzheng Zhang, En Mu
OBJECTIVE: To explore the correlation between thromboelastography (TEG) parameters and the risk of venous thromboembolism (VTE) and bleeding in patients receiving anticoagulant therapy in surgical intensive care unit (SICU). METHODS: 205 patients received low molecular weight heparin (LMWH) anticoagulant therapy admitted to SICU of Tianjin Hospital from December 2016 to December 2017 were consecutively enrolled. TEG detection was performed in all patients at 1 day after anticoagulation therapy, and coagulation reaction time (R value), blood clot generation time (K value), blood clot generation rate (α angle) and maximum width value (MA value) were recorded...
July 2018: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
keyword
keyword
169606
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.